文献速递冠心病血脂与心血管预防

老年退伍军人冠心病患者吸食大麻与心血管事件的关联

Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
PubMed 文献 · Circulation · 2025-07-21

该研究纳入4285例66~68岁冠心病退伍军人,按近30天吸食大麻状态分组随访3.3年,发现吸食大麻与急性心肌梗死、卒中和心血管死亡的复合结局无独立关联(校正HR 0.87,95%CI 0.61-1.24)。

要点

  • 在老年冠心病退伍军人中,近30天吸食大麻与复合心血管事件无独立关联。
  • 复合结局包括致死/非致死性卒中、急性心肌梗死及心血管死亡。
  • 任何形式大麻使用(吸烟、电子烟、食用等)与复合结局亦无关联。

核心结论

  • 在老年冠心病退伍军人中,自我报告的大麻使用与平均3.3年随访期间的心血管事件增加无独立关联。

研究设计与样本

  • THC队列(心脏与大麻)纳入4285例1950至1952年出生的冠心病退伍军人,平均年龄67.5岁,2%为女性。
  • 2018年4月5日至2020年3月12日招募,通过电话访谈收集健康行为,按近30天自我报告吸食大麻状态分类。
  • 另按近30天任何形式大麻使用(吸烟、电子烟或食用)与不使用分类,随访至2022年6月14日。

主要发现

  • 队列中1015例报告近30天吸食大麻,3122例未吸食,平均随访3.3年,发生563例事件。
  • 与不吸食大麻者相比,近30天吸食大麻与急性心肌梗死、卒中和心血管死亡的复合结局无关联(校正HR 0.87,95%CI 0.61-1.24)。
  • 近30天任何形式大麻使用(吸烟、电子烟、 dab、食用)与复合结局亦无关联。

临床怎么用

  • 对于老年冠心病患者,不应仅基于大麻使用史判断其心血管事件风险增高。
  • 仍需个体化评估大麻使用,结合其他危险因素综合管理。

局限性

  • 研究为观察性队列,大麻使用基于自我报告,可能存在残余混杂和错分偏倚。
  • 样本以男性为主(2%女性),平均随访3.3年,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to 68 years of age) with coronary artery disease. METHODS: The THC Cohort (Heart and Cannabis) comprised 4285 veterans (mean [SD] age, 67.5 [1.01] years; 2% female) with coronary artery disease who were born in 1950 to 1952. Participants were recruited between April 5, 2018, and March 12, 2020, interviewed about health behaviors, and then classified according to their self-reported cannabis smoking status in the previous 30 days. In a separate analysis, we classified participants according to any form of cannabis use (smoking, vaping, or edible use) versus nonuse in the past 30 days. Data on demographic, behavioral, and clinical characteristics were collected by telephone interview and from national Department of Veterans Affairs and Medicare data sources. The primary outcome included a composite of fatal and nonfatal stroke, fatal and nonfatal acute myocardial infarction, and cardiovascular death. The follow-up period for each patient extended from the date of their initial interview until the end of study (June 14, 2022). All participants were followed until they experienced an outcome or until the end of the follow-up period. Survey nonresponse weights and propensity score-based weights were used to reduce bias and confounding. Hazard ratios were estimated using cause-specific hazard models. RESULTS: The cohort included 1015 veterans with coronary artery disease who reported smoking cannabis in the previous 30 days and 3122 veterans who did not smoke cannabis in the previous 30 days. Mean follow-up was 3.3 years, and 563 events occurred. Compared with veterans who did not smoke cannabis, smoking cannabis (past 30 days) was not associated with the composite outcome of acute myocardial infarction, stroke, and cardiovascular death (adjusted hazard ratio, 0.87 [95% CI, 0.61-1.24]). Similarly, use of any form of cannabis (smoking, vaping, dabbing, edibles) in the past 30 days was not associated with the composite outcome. CONCLUSIONS: In this cohort of older veterans with coronary artery disease, self-reported cannabis use was not independently associated with increased cardiovascular events over a mean of 3.3 years of follow-up.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Keyhani S, Cohen BE, Vali M, et al. Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease. Circulation. 2025. PMID: 40686207. doi:10.1161/CIRCULATIONAHA.124.073193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。